AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Challenges and Advances in Lp(a) Treatment
This chapter explores the difficulties in lowering lipoprotein(a) levels and clarifies that lifestyle changes and statins do not impact them. It also discusses ongoing clinical trials for the drug pellicarsin, with potential results expected by 2025, highlighting the public health implications of elevated Lp(a) levels worldwide.